Cerebellar dysfunction and schizophrenia-like behavior in Ebp1-deficient mice

Mol Psychiatry. 2022 Apr;27(4):2030-2041. doi: 10.1038/s41380-022-01458-1. Epub 2022 Feb 15.

Abstract

Cerebellar deficits with Purkinje cell (PCs) loss are observed in several neurologic disorders. However, the underlying mechanisms as to how the cerebellum is affected during development remain unclear. Here we demonstrated that specific inactivation of murine Ebp1 in the central nervous system causes a profound neuropathology characterized by reduced cerebellar volume and PCs loss with abnormal dendritic development, leading to phenotypes including motor defects and schizophrenia (SZ)-like behaviors. Loss of Ebp1 leads to untimely gene expression of Fbxw7, an E3 ubiquitin ligase, resulting in aberrant protein degradation of PTF1A, thereby eliciting cerebellar defects. Reinstatement of Ebp1, but not the Ebp1-E183Ter mutant found in SZ patients, reconstituted cerebellar architecture with increased PCs numbers and improved behavioral phenotypes. Thus, our findings indicate a crucial role for EBP1 in cerebellar development, and define a molecular basis for the cerebellar contribution to neurologic disorders such as SZ.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cerebellar Diseases* / metabolism
  • Cerebellum / pathology
  • DNA-Binding Proteins / metabolism*
  • Humans
  • Mice
  • Purkinje Cells / metabolism
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / metabolism*
  • Schizophrenia* / metabolism

Substances

  • DNA-Binding Proteins
  • Pa2g4 protein, mouse
  • RNA-Binding Proteins